60 Degrees Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 400.00% vs 0.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -4.55% vs -152.38% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.50",
          "val2": "0.10",
          "chgp": "400.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-2.10",
          "chgp": "-9.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.30",
          "val2": "-2.20",
          "chgp": "-4.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4,399.70%",
          "val2": "-14,304.80%",
          "chgp": "990.51%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 133.33% vs -40.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -110.53% vs 38.71% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.30",
          "chgp": "133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.70",
          "val2": "-5.10",
          "chgp": "-90.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "2.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.70",
          "val2": "3.70",
          "chgp": "-54.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-8.00",
          "val2": "-3.80",
          "chgp": "-110.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14,258.50%",
          "val2": "-20,327.80%",
          "chgp": "606.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

0.50

0.10

400.00%

Operating Profit (PBDIT) excl Other Income

-2.30

-2.10

-9.52%

Interest

0.00

0.00

Exceptional Items

-0.00

-0.10

100.00%

Consolidate Net Profit

-2.30

-2.20

-4.55%

Operating Profit Margin (Excl OI)

-4,399.70%

-14,304.80%

990.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 400.00% vs 0.00% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -4.55% vs -152.38% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.70

0.30

133.33%

Operating Profit (PBDIT) excl Other Income

-9.70

-5.10

-90.20%

Interest

0.00

2.30

-100.00%

Exceptional Items

1.70

3.70

-54.05%

Consolidate Net Profit

-8.00

-3.80

-110.53%

Operating Profit Margin (Excl OI)

-14,258.50%

-20,327.80%

606.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 133.33% vs -40.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -110.53% vs 38.71% in Dec 2023

All Annual Results